» Articles » PMID: 27791948

The Association Between the Parenchymal Neurological Involvement and Posterior Uveitis in Behçet's Syndrome

Overview
Specialty Rheumatology
Date 2016 Oct 30
PMID 27791948
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Behçet's syndrome (BS) is a systemic vasculitis, which may involve multiple organ systems simultaneously. Clinical findings in BS often fit into well-recognized patterns, such as the association between papulo-pustular skin lesions and arthritis. We have recently observed a distinct pattern, in which a subtype of neuro-Behçet's syndrome (NBS) is often preceded by specific ophthalmic manifestations of the disease process. The purpose of this study is to evaluate the association between the parenchymal subtype of NBS and posterior uveitis (PU).

Methods: We have retrospectively reviewed the clinical records of 295 patients with BS, who met the international classification criteria for BS, diagnosed at two major rheumatology clinics from 2010 to 2014. Patient demographics, ophthalmic examinations, clinical and radiologic patterns of neurological involvement were recorded. Manifestations of BS were classified as PU, NBS, vascular involvement, and arthritis. The association between clinical findings was analysed for statistical significance.

Results: Of the 295 patients, 100 had PU and 44 had NBS. 30 patients had parenchymal NBS and 14 had vascular NBS. Patients with PU were significantly more likely to have neurological involvement compared to those without PU (p<0.001; Odds Ratio: 3.924; 95% CI: 1.786-8.621). Rate of posterior uveitis was higher in patients with parenchymal NBS when compared to patients with vascular NBS, vascular BS or arthritis (63.3%, 21.4%, 22% and 4.2% respectively, p<0.001).

Conclusions: Our findings suggest a clinically and statistically significant association between posterior uveitis and parenchymal type of neurologic involvement in BS. The development of posterior uveitis in a patient with previously diagnosed BS should be recognized as a "warning sign" for predisposition to neurologic involvement. These patients should be informed about the possible signs and symptoms of neurological involvement, which can cause very rapid and irreversible damage unless recognized and treated immediately.

Citing Articles

Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.

Guan Y, Li F, Li N, Yang P J Neuroinflammation. 2024; 21(1):133.

PMID: 38778397 PMC: 11112928. DOI: 10.1186/s12974-024-03123-6.


Ocular Manifestations of Behçet's Disease: An Update on Diagnostic Challenges and Disease Management.

Zajac H, Turno-Krecicka A J Clin Med. 2021; 10(21).

PMID: 34768694 PMC: 8584626. DOI: 10.3390/jcm10215174.


Prognostic factors for relapse and poor outcome in neuro-Behçet's syndrome: results from a clinical long-term follow-up of a single centre.

Sahin Eroglu D, Torgutalp M, Yucesan C, Sezer S, Yayla M, Boyvat A J Neurol. 2021; 269(4):2046-2054.

PMID: 34482435 DOI: 10.1007/s00415-021-10787-0.


Behçet's Syndrome Apart From the Triple Symptom Complex: Vascular, Neurologic, Gastrointestinal, and Musculoskeletal Manifestations. A Mini Review.

Kotter I, Lotscher F Front Med (Lausanne). 2021; 8:639758.

PMID: 33898481 PMC: 8063110. DOI: 10.3389/fmed.2021.639758.


Characteristics and phenotype heterogeneity in late-onset Behçet's syndrome: a cohort from a referral center in China.

Zou J, Luo D, Shen Y, Guan J Clin Rheumatol. 2021; 40(6):2319-2326.

PMID: 33411142 DOI: 10.1007/s10067-020-05536-z.